Showing results (311-320 of 333) with videos related to
Sort By:
Pageof 34
The Journal of Clinical Endocrinology and Metabolism|February 18, 1999
A mouse monoclonal antibody to a thyrotropin receptor ectodomain variant provides insight into the exquisite antigenic conformational requirement, epitopes and in vivo concentration of human autoantibodiesG D Chazenbalk, Y Wang, J Guo, et al.International Journal of Antimicrobial Agents|August 11, 2007
Bacteraemia in febrile neutropenic cancer patientsJ Klastersky, L Ameye, J Maertens, et al.Clinical and Experimental Immunology|November 1, 1990
Thyroid autoantigens and human T cell responsesN Fukuma, S M McLachlan, B Rapoport, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 2, 2010
Growth factor receptors gene expression and Akt phosphorylation in benign human thyroid nodules are unaffected by chronic thyrotropin suppressionM L Sponziello, R Bruno, C Durante, et al.Journal of Endocrinological Investigation|December 14, 2007
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivatesR Morisi, M Celano, E Tosi, et al.Journal of Endocrinological Investigation|March 18, 2023
The role of miR-139-5p in radioiodine-resistant thyroid cancerV Pecce, M Sponziello, A Verrienti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2003
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapyR de Wit, J Herrstedt, B Rapoport, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 10, 2012
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individualsM Maranghi, S Prudente, L D'Erasmo, et al.Journal of Endocrinological Investigation|August 12, 1998
Analysis of RET proto-oncogene abnormalities in patients with MEN 2A, MEN 2B, familial or sporadic medullary thyroid carcinomaE Chiefari, D Russo, D Giuffrida, et al.Archives of Internal Medicine|October 28, 1996
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid AssociationP A Singer, D S Cooper, G H Daniels, et al.Pageof 34